The SmeYZ efflux pump of stenotrophomonas maltophilia contributes to drug resistance, virulence-related characteristics, and virulence in mice

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 7, 2015, Pages 4067-4073

  Lin, Yi Tsung ^a,b   Huang, Yi Wei ^b   Chen, Shiang Jiuun ^c   Chang, Chia Wei ^b   Yang, Tsuey Ching ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CEFOXITIN; CEFUROXIME; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; KANAMYCIN; KITASAMYCIN; NALIDIXIC ACID; PIPERACILLIN; PROTEINASE; TETRACYCLINE; BACTERIAL PROTEIN; CARRIER PROTEIN; DISINFECTANT AGENT; HYDROGEN PEROXIDE; MENADIONE; PEPTIDE HYDROLASE; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BIOFILM; CONTROLLED STUDY; DELETION MUTANT; ENZYME ACTIVITY; FLAGELLUM; HUMAN; HUMAN CELL; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SEPTICEMIA; SERUM; SMEYZ GENE; STENOTROPHOMONAS MALTOPHILIA; ANIMAL; C57BL MOUSE; CHEMISTRY; GENE DELETION; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE; MUTATION; PATHOGENICITY; VIRULENCE;

ANIMALS; BACTERIAL PROTEINS; BIOFILMS; DISINFECTANTS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLAGELLA; GENE DELETION; HUMANS; HYDROGEN PEROXIDE; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICROBIAL SENSITIVITY TESTS; MUTATION; NEUTROPHILS; PEPTIDE HYDROLASES; STENOTROPHOMONAS MALTOPHILIA; VIRULENCE; VIRULENCE FACTORS; VITAMIN K 3;

EID: 84935858075     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00372-15     Document Type: Article

References (50)

1. Sanchez MB, Hernandez A, Martinez JL. 2009. Stenotrophomonas maltophilia drug resistance. Future Microbiol 4:655-660. http://dx.doi.org/10.2217/fmb.09.45.
2. Brooke JS. 2012. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev 25:2-41. http://dx.doi.org/10.1128/CMR.00019-11.
3. Bolhuis H, van Veen HW, Poolman B, Driessen AJ, Konings WN. 1997. Mechanisms of multidrug transporters. FEMS Microbiol Rev 21:55-84. http://dx.doi.org/10.1111/j.1574-6976.1997.tb00345.x.
4. Misra R, Bavro VN. 2009. Assembly and transport mechanism of tripartite drug efflux systems. Biochim Biophys Acta 1794:817-825. http://dx.doi.org/10.1016/j.bbapap.2009.02.017.
5. Poole K. 2008. Bacteria multidrug efflux pumps serve other functions. Microbe Mag 3:179-185.
6. Baugh S, Ekanayaka AS, Piddock LJV, Webber MA. 2012. Loss of or inhibition of all multidrug resistance efflux pumps of Salmonella enterica serovar Typhimurium results in impaired ability to form a biofilm. J Antimicrob Chemother 67:2409-2417. http://dx.doi.org/10.1093/jac/dks228.
7. Chan YY, Chua KL. 2005. The Burkholderia pseudomallei BpeAB-OprB efflux pump: expression and impact on quorum sensing and virulence. J Bacteriol 187:4707-4719. http://dx.doi.org/10.1128/JB.187.14.4707-4719.2005.
8. Pérez A, Poza M, Fernández A, Fernández M del C, Mallo S, Merino M, Rumbo-Feal S, Cabral MP, Bou G. 2012. Involvement of the AcrAB-TolC efflux pump in the resistance, fitness, and virulence of Enterobacter cloacae. Antimicrob Agents Chemother 56:2084-2090. http://dx.doi.org/10.1128/AAC.05509-11.
9. Lister IM, Raftery C, Mecsas J, Levy SB. 2012. Yersinia pestis AcrAB-TolC in antibiotic resistance and virulence. Antimicrob Agents Chemother 56:1120-1123. http://dx.doi.org/10.1128/AAC.05338-11.
10. Chen H, Hu J, Chen PR, Lan L, Li Z, Hicks LM, Dinner AR, He C. 2008. The Pseudomonas aeruginosa multidrug efflux regulator MexR uses an oxidation-sensing mechanism. Proc Natl Acad Sci U S A 105:13586-13591. http://dx.doi.org/10.1073/pnas.0803391105.
11. Fraud S, Poole K. 2011. Oxidative stress induction of the MexXY multidrug efflux genes and promotion of aminoglycoside resistance development in Pseudomonas aeruginosa. Antimicrob Agents Chemother 55: 1068-1074. http://dx.doi.org/10.1128/AAC.01495-10.
12. Palyada K, Sun YQ, Flint A, Butcher J, Naikare H, Stintzi A. 2009. Characterization of the oxidative stress stimulon and PerR regulon of Campylobacter jejuni. BMC Genomics 10:481. http://dx.doi.org/10.1186/1471-2164-10-481.
13. Fetar H, Gilmour C, Klinoski R, Daigle DM, Dean CR, Poole K. 2011. MexEF-OprN multidrug efflux operon of Pseudomonas aeruginosa: regulation by the MexT activator in response to nitrosative stress and chloramphenicol. Antimicrob Agents Chemother 55:508-514. http://dx.doi.org/10.1128/AAC.00830-10.
14. Fraud S, Campigotto AJ, Chen Z, Poole K. 2008. MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa: involvement in chlorhexidine resistance and induction by membrane-damaging agents dependent upon the AlgU stress response sigma factor. Antimicrob Agents Chemother 52:4478-4482. http://dx.doi.org/10.1128/AAC.01072-08.
15. Crossman LC, Gould VC, Dow JM, Vernikos GS, Okazaki A, Sebaihia M, Saunders D, Arrowsmith C, Carver T, Peters N, Adlem E, Kerhornou A, Lord A, Murphy L, Seeger K, Squares R, Rutter S, Quail MA, Rajandream MA, Harris D, Churcher C, Bentley SD, Parkhill J, Thomson NR, Avison MB. 2008. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol 9:R74. http://dx.doi.org/10.1186/gb-2008-9-4-r74.
16. Li XZ, Zhang L, Poole K. 2002. SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 46:333-343. http://dx.doi.org/10.1128/AAC.46.2.333-343.2002.
17. Alonso A, Martinez JL. 2000. Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob Agents Chemother 44:3079-3086. http://dx.doi.org/10.1128/AAC.44.11.3079-3086.2000.
18. E-mediated envelope stress response in Stenotrophomonas maltophilia. PLoS One 9:e111784. http://dx.doi.org/10.1371/journal.pone.0111784.
19. Lin CW, Huang YW, Hu RM, Yang TC. 2014. SmeOP-TolCsm efflux pump contributes to the multidrug resistance of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 58:2405-2408. http://dx.doi.org/10.1128/AAC.01974-13.
20. Chen CH, Huang CC, Chung TC, Hu RM, Huang YW, Yang TC. 2011. Contribution of resistance-nodulation-division efflux pump operon smeU1-V-W-U2-X to multidrug resistance of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 55:5826-5833. http://dx.doi.org/10.1128/AAC.00317-11.
21. Gould VC, Okazaki A, Avison MB. 2013. Coordinate hyperproduction of SmeZ and SmeJK efflux pumps extends drug resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 57:655-657. http://dx.doi.org/10.1128/AAC.01020-12.
22. Hu RM, Huang KJ, Wu LT, Hsiao YJ, Yang TC. 2008. Induction of L1 and L2 β-lactamases of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 52:1198-1200. http://dx.doi.org/10.1128/AAC.00682-07.
23. Yang TC, Huang YW, Hu RM, Huang SC, Lin YT. 2009. AmpDI is involved in expression of chromosomal L1 and L2 β-lactamases of Stenotrophomonas maltophilia. Antimicrob Agents Chemother 53:2902-2907. http://dx.doi.org/10.1128/AAC.01513-08.
24. Lin CW, Chiou CS, Chang YC, Yang TC. 2008. Comparison of pulsed-field gel electrophoresis and three rep-PCR methods for evaluating the genetic relatedness of Stenotrophomonas maltophilia isolates. Lett Appl Microbiol 47:393-398. http://dx.doi.org/10.1111/j.1472-765X.2008.02443.x.
25. nd informational supplement. CLSI document M100-S22. Clinical and Laboratory Standards Institute, Wayne, PA.
26. Zhao X, Wang Y, Shang Q, Li Y, Hao H, Zhang Y, Guo Z, Yang G, Xie Z, Wang R. 2015. Collagen-like proteins (ClpA, ClpB, ClpC, and ClpD) are required for biofilm formation and adhesion to plant roots by Bacillus amyloliquefaciens FZB42. PLoS One 10:e0117414. http://dx.doi.org/10.1371/journal.pone.0117414.
27. Hoopman TC, Liu W, Joslin SN, Pybus C, Brautigam CA, Hansen EJ. 2011. Identification of gene products involved in the oxidative stress response of Moraxella catarrhalis. Infect Immun 79:745-755. http://dx.doi.org/10.1128/IAI.01060-10.
28. Murray TS, Kazmierczak BI. 2006. FlhF is required for swimming and swarming in Pseudomonas aeruginosa. J Bacteriol 188:6995-7004. http://dx.doi.org/10.1128/JB.00790-06.
29. Kirov SM, Tassell BC, Semmler ABT, O'Donovan LA, Rabaan AA, Shaw JG. 2002. Lateral flagella and swarming motility in Aeromonas species. J Bacteriol 184:547-555. http://dx.doi.org/10.1128/JB.184.2.547-555.2002.
30. Lin YT, Huang YW, Liou RS, Yang TC. 2014. MacABCsm, an ABC-type tripartite efflux pump of Stenotrophomonas maltophilia, involved in drug resistance, oxidative and envelope stress tolerance, and biofilm formation. J Antimicrob Chemother 69:3221-3226. http://dx.doi.org/10.1093/jac/dku317.
31. Kumar L, Chhibber S, Harjai K. 2014. Structural alterations in Pseudomonas aeruginosa by zingerone contribute to enhanced susceptibility to antibiotics, serum and phagocytes. Life Sci 117:24-32. http://dx.doi.org/10.1016/j.lfs.2014.09.017.
32. Dacheux D, Attree I, Schneider C, Toussaint B. 1999. Cell death of human polymorphonuclear neutrophils induced by a Pseudomonas aeruginosa cystic fibrosis isolate requires a functional type III secretion system. Infect Immun 67:6164-6167.
33. Pan CY, Chen JC, Sheen JF, Lin TL, Chen JY. 2014. Epinecidin-1 has immunomodulatory effects, facilitating its therapeutic use in a mouse model of Pseudomonas aeruginosa sepsis. Antimicrob Agents Chemother 58:4264-4274. http://dx.doi.org/10.1128/AAC.02958-14.
34. Toleman MA, Bennett PM, Bennett DM, Jones RN, Walsh TR. 2007. Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes. Emerg Infect Dis 13:559-565. http://dx.doi.org/10.3201/eid1304.061378.
35. Huang YW, Hu RM, Lin YT, Huang HH, Yang TC. 2015. The contribution of class 1 integron to antimicrobial resistance in Stenotrophomonas maltophilia. Microb Drug Resist 21:90-96. http://dx.doi.org/10.1089/mdr.2014.0072.
36. Josenhans C, Suerbaum S. 2002. The role of motility as a virulence factor in bacteria. Int J Med Microbiol 291:605-614. http://dx.doi.org/10.1078/1438-4221-00173.
37. Duan Q, Zhou M, Zhu L, Zhu G. 2013. Flagella and bacterial pathogenicity. J Basic Microbiol 53:1-8. http://dx.doi.org/10.1002/jobm.201100335.
38. Wood TK, Gonzalez AF, Herzberg M, Lee J. 2006. Motility influences biofilm architecture in Escherichia coli. Appl Microbiol Biotechnol 72:361-367. http://dx.doi.org/10.1007/s00253-005-0263-8.
39. Lemon KP, Higgins DE, Kolter R. 2007. Flagellar motility is critical for Listeria monocytogenes biofilm formation. J Bacteriol 189:4418-4424. http://dx.doi.org/10.1128/JB.01967-06.
40. Kim TJ, Young BM, Young GM. 2008. Effect of flagellar mutations on Yersinia enterocolitica biofilm formation. Appl Environ Microbiol 74:5466-5474. http://dx.doi.org/10.1128/AEM.00222-08.
41. Vaisman N, Kerasin E, Hahn T, Trifon S, Voet H, Tabachnik E. 1994. Increased neutrophil chemiluminescence production in patients with cystic fibrosis. Metabolism 43:719-722. http://dx.doi.org/10.1016/0026-0495(94)90120-1.
42. Ciofu O, Riis B, Pressler T, Poulsen HE, Høiby N. 2005. Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob Agents Chemother 49:2276-2282. http://dx.doi.org/10.1128/AAC.49.6.2276-2282.2005.
43. Bogomolnaya LM, Andrews KD, Talamantes M, Maple A, Ragoza Y, Vazquez-Torres A, Andrews-Polymenis H. 2013. The ABC-type efflux pump MacAB protects Salmonella enterica serovar Typhimurium from oxidative stress. mBio 4:e00630-13. http://dx.doi.org/10.1128/mBio.00630-13.
44. Bina XR, Provenzano D, Nguyen N, Bina JE. 2008. Vibrio clolerae RND family efflux pump systems are required for antimicrobial resistance, optimal virulence factor production, and colonization of the infant mouse small intestine. Infect Immun 76:3595-3605. http://dx.doi.org/10.1128/IAI.01620-07.
45. Taylor DL, Bina XR, Bina JE. 2012. Vibrio cholera VexH encodes a multiple drug efflux pump that contributes to the production of cholera toxin and the toxin co-regulated pilus. PLoS One 7:e38208. http://dx.doi.org/10.1371/journal.pone.0038208.
46. Coudeyras S, Nakusi L, Charbonnel N, Forestier C. 2008. A tripartite efflux pump involved in gastrointestinal colonization by Klebsiella pneumonia confers a tolerance response to inorganic acid. Infect Immun 76:4633-4641. http://dx.doi.org/10.1128/IAI.00356-08.
47. Pletzer D, Weingart H. 2014. Characterization and regulation of the resistance-nodulation-cell division-type multidrug efflux pumps MdtABC and MdtUVW from the fire blight pathogen Erwinia amylovora. BMC Microbiol 14:185. http://dx.doi.org/10.1186/1471-2180-14-185.
48. Lamarche MG, Deziel E. 2011. MexEF-OprN efflux pump exports the Pseudomonas quinolone signal (PQS) precursor HHQ (4-hydroxy-2-heptylquinoline). PLoS One 6:e24310. http://dx.doi.org/10.1371/journal.pone.0024310.
49. Alonso A, Morales G, Escalante R, Campanario E, Sastre L, Martinez JL. 2004. Overexpression of the multidrug efflux pump SmeDEF impairs Stenotrophomonas maltophilia physiology. J Antimicrob Chemother 53:432-434. http://dx.doi.org/10.1093/jac/dkh074.
50. Warner DM, Shafer WM, Jerse AE. 2008. Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. Mol Microbiol 70:462-478. http://dx.doi.org/10.1111/j.1365-2958.2008.06424.x.